ARCHX
Price
$19.42
Change
-$0.03 (-0.15%)
Updated
Oct 7 closing price
Net Assets
56.52M
RLBAX
Price
$38.56
Change
-$0.09 (-0.23%)
Updated
Oct 7 closing price
Net Assets
266.1B
Interact to see
Advertisement

ARCHX vs RLBAX

Header iconARCHX vs RLBAX Comparison
Open Charts ARCHX vs RLBAXBanner chart's image
Archer Balanced
Price$19.42
Change-$0.03 (-0.15%)
VolumeN/A
Net Assets56.52M
American Funds American Balanced R1
Price$38.56
Change-$0.09 (-0.23%)
VolumeN/A
Net Assets266.1B
ARCHX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
ARCHX vs. RLBAX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCHX is a Buy and RLBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 266B vs. ARCHX (56.5M). ARCHX pays higher dividends than RLBAX: ARCHX (1.30) vs RLBAX (1.10). ARCHX was incepted earlier than RLBAX: ARCHX (20 years) vs RLBAX (23 years). ARCHX (1.31) and RLBAX (1.31) have similar cost to investors . RLBAX is a more actively managed with annual turnover of: 44.00 vs. ARCHX (11.69). RLBAX has a lower initial minimum investment than ARCHX: RLBAX (250) vs ARCHX (2500). ARCHX (9.16) and RLBAX (9.12) have marching annual gain over last year. ARCHX return over 5 years is better than : 49.13 vs. RLBAX (38.04).
ARCHXRLBAXARCHX / RLBAX
Total Expense Ratio1.211.3192%
Annual Report Gross Expense Ratio1.311.31100%
Fund Existence20 years23 years-
Gain YTD12.09613.77088%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets56.5M266B0%
Annual Yield % from dividends1.301.10118%
Returns for 1 year9.169.12100%
Returns for 3 years45.0447.9894%
Returns for 5 years49.1338.04129%
Returns for 10 years94.1168.72137%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WLY38.330.03
+0.09%
John Wiley & Sons
ROIV16.12-0.14
-0.86%
Roivant Sciences Ltd
PRLD1.44-0.02
-1.37%
Prelude Therapeutics
IVP0.98-0.03
-3.18%
Inspire Veterinary Partners Inc
GRRR19.99-0.68
-3.29%
Gorilla Technology Group